IRIS

CAZZOLA, MARIO

CAZZOLA, MARIO  

DIPARTIMENTO DI MEDICINA INTERNA E TERAPIA MEDICA  

Mostra records
Risultati 1 - 20 di 513 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
"In vitro" megakaryocytopoiesis in patients with HIV-related thrombocytopenic purpura. 1-gen-1988 Stella, Cc; Bergamaschi, G; Nalli, G; Cazzola, Mario
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 1-gen-1990 Cazzola, M; Pedrazzoli, P; Bergamaschi, G; Buonanno, C; Cuomo, A; D'Uva, R; Ponchio, L; Rosti, V; Zappone, E; Ascari, E
A B-cell lymphoproliferative disorder 1-gen-2004 Invernizzi, Rosangela; Cazzola, Mario
A case of persistent eosinophilia 1-gen-2004 Invernizzi, Rosangela; Cazzola, Mario
A chronic lymphoproliferative disorder 1-gen-2004 Invernizzi, Rosangela; Cazzola, Mario
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. 1-gen-2017 Passamonti, F; Giorgino, T; Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Caramazza, D; Merli, M; Pietra, D; Casalone, R; Rotunno, G; Barbui, T; Cazzola, M; Vannucchi, Am.
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data 1-gen-2020 Nicora, G.; Moretti, F.; Sauta, E.; Della Porta, M.; Malcovati, L.; Cazzola, M.; Quaglini, S.; Bellazzi, R.
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 1-gen-2008 Passamonti, Francesco; Rumi, Elisa; Caramella, M; Elena, Chiara; Arcaini, Luca; Boveri, E; Del Curto, C; Pietra, D; Vanelli, L; Bernasconi, Paolo; Pascutto, C; Cazzola, Mario; Morra, E; Lazzarino, Mario
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) 1-gen-2010 Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, Elisa; Pereira, A; Guglielmelli, P; Pungolino, E; Caramella, M; Maffioli, M; Pascutto, C; Lazzarino, Mario; Cazzola, Mario; Tefferi, A.
A gain-of-function mutation of JAK2 in myeloproliferative disorders 1-gen-2005 Kralovics, R; Passamonti, Francesco; Buser, As; Teo, Ss; Tiedt, R; Passweg, Jr; Tichelli, A; Cazzola, Mario; Skoda, Rc
A global strategy for prevention and detection of blood doping with erythropoietin and related drugs 1-gen-2000 Cazzola, Mario
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. 1-gen-1995 Girelli, D; Olivieri, O; De Franceschi, L; Corrocher, R; Bergamaschi, G; Cazzola, Mario
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. 1-gen-2014 Lussana, F; Carobbio, A; Randi, Ml; Elena, Chiara; Rumi, Elisa; Finazzi, G; Bertozzi, I; Pieri, L; Ruggeri, M; Palandri, F; Polverelli, N; Elli, E; Tieghi, A; Iurlo, A; Ruella, M; Cazzola, Mario; Rambaldi, A; Vannucchi, Am; Barbui, T.
A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation 1-gen-1999 Barosi, G; M., Marchetti; P., Alessandrino; Locatelli, Franco; S., Casula; M., Lunghi; Cazzola, Mario; E., Giraldi; C., Bernasconi
A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. 1-gen-1997 Cazzola, Mario; Borgna Pignatti, C; Locatelli, Franco; Ponchio, L; Beguin, Y; De Stefano, P.
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 1-gen-1999 Merlini, Giampaolo; Anesi, E; Palladini, Giovanni; Perfetti, V; Obici, L; Invernizzi, Rosangela; Balduini, Carlo; Ascari, Edoardo; Cazzola, Mario
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron 1-gen-2008 Melis, Ma; Cau, M; Congiu, R; Sole, G; Barella, S; Cao, A; Westerman, M; Cazzola, Mario; Galanello, R.
A novel deletion of the L-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome. 1-gen-2002 Cazzola, Mario; Foglieni, B; Bergamaschi, G; Levi, S; Lazzarino, M; Arosio, P.
A novel germline JAK2 mutation in familial myeloproliferative neoplasms. 1-gen-2014 Rumi, Elisa; Harutyunyan, As; Casetti, I; Pietra, D; Nivarthi, H; Moriggl, R; Cleary, C; Bagienski, K; Astori, C; Bellini, M; Berg, T; Passamonti, F; Kralovics, R; Cazzola, Mario
A patient-oriented approach to treatment of myelodysplastic syndromes. 1-gen-1998 Cazzola, Mario; Anderson, Je; Ganser, A; Hellström Lindberg, E.